Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Wealth of clinical data support efficacy of ziprasidone

Sep. 23, 1998

New uses for olanzapine: psychosis in AD patients and cognition disorders in schizophrenics

Sep. 23, 1998

New phthalazine derivatives with antipsychotic-like properties

Sep. 23, 1998

Another SSRI success story: sertraline safe and effective in patients with panic disorder

Sep. 23, 1998

Sodium channel blocker with antiischemic potential emerges from Glaxo Wellcome R&D

Sep. 22, 1998

Another mGluR1 receptor ligand reported by Lilly

Sep. 22, 1998

Kyowa Hakko reports success in its search for new analgesics

Sep. 22, 1998

Toa Eiyo discloses new adenosine A1 antagonists

Sep. 22, 1998

Nortran completes phase II trial of RSD-921

Sep. 22, 1998

Cognition enhancer on the clinical track at Dainippon

Sep. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...